Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer <it>in vitro </it>and <it>in vivo </it>in mice
<p>Abstract</p> <p>Background</p> <p>The objective of this study was to develop a ligand-targeted photodynamic therapy (tPDT) by conjugating factor VII (fVII) protein with photosensitiser verteporfin in order to overcome the poor selectivity and enhance the effect of no...
Main Authors: | Rao Benqiang, Hu Zhiwei, Chen Shimin, Duanmu Jinzhong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/235 |
Similar Items
-
Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
by: Prashant Jain, et al.
Published: (2018-01-01) -
Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy
by: Tock-Han Lim, et al.
Published: (2013-06-01) -
Photodynamic Therapy with Verteporfin for Choroidal Metastasis Refractory to Radiotherapy
by: Raymond Zhou, et al.
Published: (2019-11-01) -
Commentary: Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
by: Atul Kumar, et al.
Published: (2018-01-01) -
Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy
by: Vida Mashayekhi, et al.
Published: (2020-09-01)